301 related articles for article (PubMed ID: 26418387)
1. [Cardiovascular risk in polycystic kidney disease].
Di Lorenzo A; Stallone G; Infante B; Grandaliano G; Schena FP
G Ital Cardiol (Rome); 2015 Sep; 16(9):479-84. PubMed ID: 26418387
[TBL] [Abstract][Full Text] [Related]
2. Hypertension in autosomal dominant polycystic kidney disease.
Chapman AB; Stepniakowski K; Rahbari-Oskoui F
Adv Chronic Kidney Dis; 2010 Mar; 17(2):153-63. PubMed ID: 20219618
[TBL] [Abstract][Full Text] [Related]
3. Renin-Angiotensin-aldosterone system in autosomal dominant polycystic kidney disease.
Tkachenko O; Helal I; Shchekochikhin D; Schrier RW
Curr Hypertens Rev; 2013 Feb; 9(1):12-20. PubMed ID: 23971639
[TBL] [Abstract][Full Text] [Related]
4. Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies.
Chapman AB
Clin J Am Soc Nephrol; 2008 Jul; 3(4):1197-204. PubMed ID: 18579674
[TBL] [Abstract][Full Text] [Related]
5. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.
Schrier RW
J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms and management of hypertension in autosomal dominant polycystic kidney disease.
Rahbari-Oskoui F; Williams O; Chapman A
Nephrol Dial Transplant; 2014 Dec; 29(12):2194-201. PubMed ID: 24463189
[TBL] [Abstract][Full Text] [Related]
7. Optimal care of autosomal dominant polycystic kidney disease patients.
Schrier RW
Nephrology (Carlton); 2006 Apr; 11(2):124-30. PubMed ID: 16669974
[TBL] [Abstract][Full Text] [Related]
8. Role of renin-angiotensin-aldosterone system gene polymorphisms and hypertension-induced end-stage renal disease in autosomal dominant polycystic kidney disease.
Ramanathan G; Elumalai R; Periyasamy S; Lakkakula B
Iran J Kidney Dis; 2014 Jul; 8(4):265-77. PubMed ID: 25001132
[TBL] [Abstract][Full Text] [Related]
9. Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?
Brosnahan GM; Abebe KZ; Moore CG; Bae KT; Braun WE; Chapman AB; Flessner MF; Harris PC; Hogan MC; Perrone RD; Rahbari-Oskoui FF; Steinman TI; Torres VE; The Halt Pkd Investigators
Curr Hypertens Rev; 2018; 14(1):39-47. PubMed ID: 29564978
[TBL] [Abstract][Full Text] [Related]
10. Autosomal dominant polycystic kidney disease: role of the renin-angiotensin system in raised blood pressure in progression of renal and cardiovascular disease.
Lawson CR; Doulton TW; MacGregor GA
J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):139-45. PubMed ID: 17094050
[TBL] [Abstract][Full Text] [Related]
11. Renin-Angiotensin-Aldosterone System Antagonism and Polycystic Kidney Disease Progression.
Hian CK; Lee CL; Thomas W
Nephron; 2016; 134(2):59-63. PubMed ID: 27476173
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular complications in autosomal dominant polycystic kidney disease.
Ecder T
Curr Hypertens Rev; 2013 Feb; 9(1):2-11. PubMed ID: 23971638
[TBL] [Abstract][Full Text] [Related]
13. Interpretation of renal volume in autosomal dominant polycystic kidney disease and relevant clinical implications.
Masoumi A; Elhassan E; Schrier RW
Iran J Kidney Dis; 2011 Jan; 5(1):1-8. PubMed ID: 21189426
[TBL] [Abstract][Full Text] [Related]
14. ACE inhibitors, left ventricular mass and renal cyst growth in ADPKD.
Schrier RW
Pharmacol Res; 2016 Dec; 114():166-168. PubMed ID: 27794499
[TBL] [Abstract][Full Text] [Related]
15. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.
Chapman AB; Johnson A; Gabow PA; Schrier RW
N Engl J Med; 1990 Oct; 323(16):1091-6. PubMed ID: 2215576
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease.
Schrier RW; McFann KK; Johnson AM
Kidney Int; 2003 Feb; 63(2):678-85. PubMed ID: 12631134
[TBL] [Abstract][Full Text] [Related]
17. Effect of enalapril on blood pressure, renal function, and the renin-angiotensin-aldosterone system in cats with autosomal dominant polycystic kidney disease.
Miller RH; Lehmkuhl LB; Smeak DD; DiBartola SP; Radin J
Am J Vet Res; 1999 Dec; 60(12):1516-25. PubMed ID: 10622161
[TBL] [Abstract][Full Text] [Related]
18. Update on pathogenesis, management, and treatment of hypertension in autosomal dominant polycystic kidney disease.
Helal I; Al-Rowaie F; Abderrahim E; Kheder A
Saudi J Kidney Dis Transpl; 2017; 28(2):253-260. PubMed ID: 28352004
[TBL] [Abstract][Full Text] [Related]
19. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
[TBL] [Abstract][Full Text] [Related]
20. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
Abassi Z; Armaly Z; Nakhoul F; Hoffman A
Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
